Dermatologicals in Peru
After months of mandatory home seclusion due to the COVID-19 pandemic, Peruvians are eagerly resuming their physical and sports activities. For this reason, sales of antifungals are expected to rise moderately in 2022 as cases of athlete’s foot rise, which is associated with exercise and humidity.
Euromonitor International's Dermatologicals in Peru report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
- Dermatologicals in Peru
- Euromonitor International
- September 2022
- List Of Contents And Tables
- DERMATOLOGICALS IN PERU
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Return of Peruvians to physical activities favours sales of topical antifungals
- Face-to-face school classes trigger sales of anti-parasitic and lice treatments
- Genomma Lab Perú SA faces favourable outlook in dermatologicals
- PROSPECTS AND OPPORTUNITIES
- Hair loss treatments generate strong interest on social media
- The return to poor eating habits is expected to boost growth of haemorrhoid treatments
- Brand awareness will remain highly relevant to drive future purchase
- CATEGORY DATA
- Table 1 Sales of Dermatologicals by Category: Value 2017-2022
- Table 2 Sales of Dermatologicals by Category: % Value Growth 2017-2022
- Table 3 NBO Company Shares of Dermatologicals: % Value 2018-2022
- Table 4 LBN Brand Shares of Dermatologicals: % Value 2019-2022
- Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2019-2022
- Table 6 Forecast Sales of Dermatologicals by Category: Value 2022-2027
- Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2022-2027
- CONSUMER HEALTH IN PERU
- EXECUTIVE SUMMARY
- Consumer health in 2022: The big picture
- 2022 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
- Table 9 Life Expectancy at Birth 2017-2022
- MARKET DATA
- Table 10 Sales of Consumer Health by Category: Value 2017-2022
- Table 11 Sales of Consumer Health by Category: % Value Growth 2017-2022
- Table 12 NBO Company Shares of Consumer Health: % Value 2018-2022
- Table 13 LBN Brand Shares of Consumer Health: % Value 2019-2022
- Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
- Table 15 Distribution of Consumer Health by Format: % Value 2017-2022
- Table 16 Distribution of Consumer Health by Format and Category: % Value 2022
- Table 17 Forecast Sales of Consumer Health by Category: Value 2022-2027
- Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook